Status:
COMPLETED
Comparing the Outcome in Patients of Acute Pancreatitis, With and Without Prophylactic Antibiotics
Lead Sponsor:
Benazir Bhutto Hospital, Rawalpindi
Conditions:
Acute Pancreatitis
Eligibility:
All Genders
18-70 years
Phase:
PHASE1
PHASE2
Brief Summary
The use of prophylactic antibiotics is beneficial in reducing the extrapancreatic infections and shorter hospital stay in patients of acute pancreatitis as compared to controls.
Detailed Description
Acute pancreatitis (AP) is an acute inflammatory condition of the pancreas that may extend to local and distant extra pancreatic tissues. AP is broadly classified as mild or severe. Most cases of AP a...
Eligibility Criteria
Inclusion
- Patients between 18 to 70 years of age with diagnosis of acute pancreatitis both mild and sever necrotizing pancreatitis.
- Patients who present within 48 hours of onset of symptoms.
Exclusion
- Patients who present after 48 hours of onset of symptoms.
- Patients already taking antibiotics.
- Patients who are immune compromised
- Patients with debilitating illness i.e. tuberculosis, chronic liver disease.
- Patients with trauma, and multiple visceral injuries
- Patients with diagnosed malignancy
Key Trial Info
Start Date :
January 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT02212392
Start Date
January 1 2013
End Date
December 1 2013
Last Update
August 8 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Benazir Bhutto Hospital
Rawalpindi, Punjab Province, Pakistan, 46000